Bruker Co. (NASDAQ:BRKR) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue lowered its position in Bruker Co. (NASDAQ:BRKRFree Report) by 4.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,866 shares of the medical research company’s stock after selling 1,680 shares during the quarter. State of Alaska Department of Revenue’s holdings in Bruker were worth $2,928,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BRKR. Farther Finance Advisors LLC lifted its stake in Bruker by 90.4% in the second quarter. Farther Finance Advisors LLC now owns 356 shares of the medical research company’s stock valued at $26,000 after buying an additional 169 shares during the last quarter. Zions Bancorporation N.A. purchased a new stake in Bruker in the first quarter valued at approximately $26,000. Altshuler Shaham Ltd purchased a new stake in Bruker in the fourth quarter valued at approximately $27,000. VisionPoint Advisory Group LLC lifted its stake in Bruker by 145.0% in the third quarter. VisionPoint Advisory Group LLC now owns 512 shares of the medical research company’s stock valued at $32,000 after buying an additional 303 shares during the last quarter. Finally, IFP Advisors Inc lifted its stake in Bruker by 67.8% in the second quarter. IFP Advisors Inc now owns 438 shares of the medical research company’s stock valued at $32,000 after buying an additional 177 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Insider Buying and Selling at Bruker

In other Bruker news, Director Hermann Fritz Requardt sold 15,000 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $90.06, for a total value of $1,350,900.00. Following the sale, the director now owns 23,147 shares of the company’s stock, valued at $2,084,618.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 28.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on BRKR shares. UBS Group boosted their price objective on Bruker from $94.00 to $102.00 and gave the company a “buy” rating in a research note on Friday, March 1st. JPMorgan Chase & Co. upgraded Bruker from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $90.00 in a research note on Wednesday, February 14th. Citigroup upped their price target on Bruker from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Wells Fargo & Company began coverage on Bruker in a research note on Tuesday, December 19th. They set an “equal weight” rating and a $72.00 price target for the company. Finally, Stifel Nicolaus upped their price target on Bruker from $63.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, February 14th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $84.29.

Get Our Latest Report on Bruker

Bruker Trading Up 0.1 %

Shares of BRKR stock opened at $91.00 on Thursday. The business’s fifty day moving average price is $84.35 and its 200 day moving average price is $72.09. Bruker Co. has a 1-year low of $53.79 and a 1-year high of $94.86. The firm has a market capitalization of $12.53 billion, a PE ratio of 31.16, a P/E/G ratio of 2.36 and a beta of 1.17. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.80 and a quick ratio of 0.99.

Bruker (NASDAQ:BRKRGet Free Report) last announced its quarterly earnings data on Tuesday, February 13th. The medical research company reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.05. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The firm had revenue of $844.50 million for the quarter, compared to analyst estimates of $809.35 million. During the same quarter in the prior year, the company posted $0.74 earnings per share. Bruker’s quarterly revenue was up 19.2% on a year-over-year basis. As a group, sell-side analysts forecast that Bruker Co. will post 2.74 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.22%. The ex-dividend date was Thursday, February 29th. Bruker’s dividend payout ratio (DPR) is 6.85%.

Bruker Company Profile

(Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

See Also

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.